BMO Capital analyst Jeffrey Silber maintains Stride (NYSE:LRN) with a Outperform and lowers the price target from $52 to $50.
A Massive Short Squeeze Is Underway: Bed Bath And A Few Favorites Are In Play
Several favorite stocks among retail traders are rocketing higher Wednesday in what could be seen as a short squeeze. Here’s a look at the stocks moving and what could be next.